Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 90

Comparing two pain management methods after robotic lung surgery

Official title: Title of Project: Liposomal Bupivacaine (Exparel) Versus Bupivacaine And Dexamethasone Intercostal Nerve Blocks For Robotic Thoracic Surgery: A Prospective Randomized Single-Blinded Clinical Trial

Run by Cooper Norcross Health · NCT03906617 · Data updated 2026-11-12

This study is testing which pain relief method works better after robotic lung surgery by comparing a special numbing medicine to a combination of numbing medicine with two other drugs.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment34 (estimated)
SponsorCooper Norcross Health
Academic / other
Locations1 site (Camden, New Jersey)
StatusRecruiting
StartedApril 10, 2019
Main results expectedApril 10, 2022
Study endsJune 10, 2022
Registry record updatedNovember 12, 2021
Trial IDNCT03906617 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for robotic wedge resection or lobectomy for lung masses.

Probably not a fit

Patients with a history of opiate abuse, chronic pain syndrome, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates pain relief following robotic lung surgery by comparing two methods of analgesia: liposomal bupivacaine and a combination of bupivacaine with epinephrine and dexamethasone. Participants will be randomly assigned to receive either treatment through intercostal nerve blocks and wound infiltration. The goal is to determine which method provides better pain control in patients undergoing robotic wedge resection or lobectomy for lung masses. This is a Phase 4 interventional study, indicating it is focused on assessing the effectiveness of these treatments in a real-world clinical setting.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing robotic lung surgery.

How similar studies have gone: While liposomal bupivacaine has been studied in various contexts, this specific comparison with bupivacaine/epinephrine + dexamethasone in robotic lung surgery is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* undergoing robotic wedge resection or lobectomy for lung mass(es)

Exclusion Criteria:

* emergency case
* history of opiate abuse
* chronic pain syndrome
* intravenous drug use
* chronic use of oral steroids
* pregnancy
* imprisonment
* body weight lower than 70 kg
* liver failure
* uninsured patients
* non-verbal patients or patients who are unable to rate their pain on a visual analogue pain scale
* history of allergic reaction to any of the drugs used in the study: bupivacaine, liposomal bupivacaine, dexamethasone

Where it's running

  • Cooper University Hospital
    Camden, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.